HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2484-2492

  Giannini, Giuseppe ^a   Di Marcotullio, Lucia ^b   Ristori, Elisabetta ^a   Zani, Massimo ^a   Crescenzi, Marco ^c   Scarpa, Susanna ^a   Piaggio, Giulia ^c   Vacca, Alessandra ^a   Peverali, Fiorenzo A ^d   Diana, Francesca ^e   Screpanti, Isabella ^a   Frati, Luigi ^a,f   Gulino, Alberto ^a,f  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d Ist Genet Biochim ed E   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

^f IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GENE PRODUCT; RETINOIC ACID;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUMOR GROWTH;

ADRENAL GLANDS; ADULT; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIFFERENTIATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HMGA2 PROTEIN; HUMANS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0033563255     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Grosschedl, R., Giese, K., and Pagel, J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet., 10: 94-100, 1994.
2. Johnson, K. R., Lehn, D. A., and Reeves, R. Alternative processing of mRNAs encoding mammalian chromosomal high-mobilily-group proteins HMG-I and HMG-Y. Mol. Cell. Biol., 9: 2114-2123, 1989.
3. Friedmann, M., Holth, L. T., Zoghbi, H. Y., and Reeves, R. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res., 21: 4259-4267, 1993.
4. Schoenmakers, E. F., Wanschura, S., Mols, R., Bullerdiek, J.. Van den Berghe, H., and Van de Ven, W. J. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat. Genet., 10: 436-444, 1995.
5. Ishwad, C. S., Shriver, M. D., Lassige, D. M., and Ferrell, R. E. The high mobility group I-C gene (HMGI-C): polymorphism and genetic localization. Hum. Genet., 99: 103-105, 1997.
6. Solomon, M. J., Strauss, F., and Varshavsky, A. A mammalian high mobility group protein recognizes any stretch of six A-T base pairs in duplex DNA. Proc. Natl. Acad. Sci. USA, 83: 1276-1280, 1986.
7. Chuvpilo, S., Schomberg, C., Gerwig, R., Heinfling, A., Reeves, R., Grummt, F., and Serfling, E. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res., 21: 5694-5704, 1993.
8. Allander, S. V., Durham, S. K., Scheimann, A. O., Wasserman, R. M., Suwanichkul, A., and Powell, D. R. Hepatic nuclear factor 3 and high mobility group I/Y proteins bind the insulin response element of the insulin-like growth factor-binding protein-1 promoter. Endocrinology, 138: 4291-4300, 1997.
9. Thanos, D., and Maniatis, T. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell, 71: 777-789, 1992.
10. Thanos, D. Mechanisms of transcriptional synergism of eukaryotic genes. The interferon-β paradigm. Hypertension, 27: 1025-1029, 1996.
11. Fashena, S. J., Reeves, R., and Ruddle, N. H. A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-β) gene regulation. Mol. Cell. Biol., 12: 894-903, 1992.
12. Yang-Yen, H. F., and Rothblum, L. I. Purification and characterization of a high-mobility-group-like DNA-binding protein that stimulates rRNA synthesis in vitro. Mol. Cell. Biol., 8: 3406-3414, 1988.
13. Zhou, X., Benson, K. F., Ashar, H. R., and Chada, K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature (Lond.), 376: 771-774, 1995.
14. Manfioletti, G., Giancotti, V., Bandiera, A., Buratti, E., Sautiere, P., Cary, P., Crane-Robinson, C., Coles, B., and Goodwin, G. H. cDNA cloning of the HMGI-C phospho-protein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res., 19: 6793-6797, 1991.
15. Rogalla, P., Drechsler, K., Frey, G., Hennig, Y., Helmke, B., Bonk, U., and Bullerdiek, J. HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am. J. Pathol., 149: 775-779, 1996.
16. Zhou, X., Benson, K. F., Przybysz, K., Liu, J., Hou, Y., Cherath, L., and Chada, K. Genomic structure and expression of the murine Hmgi-c gene. Nucleic Acids Res., 24: 4071-4077, 1996.
17. Chiappetta, G., Avantaggiato, V., Visconti, R., Fedele, M., Battista, S., Trapasso, F., Merciai, B. M., Fidanza, V., Giancotti, V., Santoro, M., Simeone, A., and Fusco, A. High level expression of the HMGI(Y) gene during embryonic development. Oncogene, 13: 2439-2446, 1996.
18. Lanahan, A., Williams, J. B., Sanders, L. K., and Nathans, D. Growth factor-induced delayed early response genes. Mol. Cell. Biol., 12: 3919-3929, 1992.
19. Giancotti, V., Pani, B., D'Andrea, P., Berlingieri, M. T., Di Fiore, P. P., Fusco, A., Vecchio, G., Philp, R., Crane-Robinson, C., Nicolas, R. H., Wright, C. A., and Goodwin, G. H. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c-myc and polyoma middle T genes. EMBO J., 6: 1981-1987, 1987.
20. Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V., and Fusco, A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol., 15: 1545-1553, 1995.
21. Kazmierczak, B., Hennig, Y., Wanschura, S., Rogalla, P., Bartnitzke, S., Van de Ven, W., and Bullerdiek, J. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res., 55: 6038-6039, 1995.
22. Staats, B., Bonk, U., Wanschura, S., Hanisch, P., Schoenmakers, E. F., Van de Ven, W. J., Bartnitzke, S., and Bullerdiek, J. A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res. Treat., 38: 299-303, 1996.
23. Geurts, J. M., Schoenmakers, E. F., and Van de Ven, W. J. Molecular characterization of a complex chromosomal rearrangement in a pleomorphic salivary gland adenoma involving the 3′-UTR of HMGIC. Cancer Genet. Cytogenet., 95: 198-205, 1997.
24. Geurts, J. M., Schoenmakers, E. F., Roijer, E., Stenman, G., and Van de Ven, W. J. Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland. Cancer Res., 57: 13-17, 1997.
25. Bol, S., Wanschura, S., Thode, B., Deichert, U., Van de Ven, W. J., Bartnitzke, S., and Bullerdiek, J. An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet. Cytogenet., 90: 88-90, 1996.
26. Kazmierczak, B., Pohnke, Y., and Bullerdiek, J. Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics, 38: 223-226, 1996.
27. Ashar, H. R., Fejzo, M. S., Tkachenko, A., Zhou, X., Fletcher, J. A., Weremowicz, S., Morton, C. C., and Chada, K. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell, 82: 57-65, 1995.
28. Berner, J. M., Meza-Zepeda, L. A., Kools, P. F., Forus, A., Schoenmakers, E. F., Van de Ven, W. J., Fodstad, O., and Myklebost, O. HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene, 14: 2935-2941, 1997.
29. Fedele, M., Berlingieri, M. T., Scala, S., Chiariotti, L., Viglietto, G., Rippel, V., Bullerdiek, J., Santoro, M., and Fusco, A. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene, 17: 413-418, 1998.
30. Bussemakers, M. J., van de Ven, W. J., Debruyne, F. M., and Schalken, J. A. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res., 51: 606-611, 1991.
31. Ram, T. G., Reeves, R., and Hosick, H. L. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res., 53: 2655-2660, 1993.
32. Chiappetta, G., Bandiera, A., Berlingieri, M. T., Visconti, R., Manfioletti, G., Battista, S., Martinez-Tello, F. J., Santoro, M., Giancotti, V., and Fusco, A. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene, 10: 1307-1314, 1995.
33. Fedele, M., Bandiera, A., Chiappetta, G., Battista, S., Viglietto, G., Manfioletti, G., Casamassimi, A., Santoro, M., Giancotti, V., and Fusco, A. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res., 56: 1896-1901, 1996.
34. Chiappetta, G., Tallini, G., De Biasio, M. C., Manfioletti, G., Martinez-Tello, F. J., Pentimalli, F., de Nigris, F., Mastro, A., Botti, G., Fedele, M., Berger, N., Santoro, M., Giancotti, V., and Fusco, A. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res., 58: 4193-4198, 1998.
35. Williams, A. J., Powell, W. L., Collins, T., and Morton, C. C. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am. J. Pathol., 150: 911-918, 1997.
36. Kazmierczak, B., Wanschura, S., Rommel, B., Bartnitzke, S., and Bullerdiek, J. Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMGI(Y) gene or its immediate surroundings. J. Natl. Cancer Inst. (Bethesda), 88: 1234-1236, 1996.
37. Xiao, S., Lux, M. L., Reeves, R., Hudson, T. J., and Fletcher, J. A. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am. J. Pathol., 150: 901-910, 1997.
38. Dal Cin, P., Wanschura, S., Christiaens, M. R., Van den Berghe, I., Moerman, P., Polito, P., Kazmierczak, B., Bullerdiek, J., and Van den Berghe, H. Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY. Genes Chromosomes Cancer, 20: 90-92, 1997.
39. Kottickal, L. V., Sarada, B., Ashar, H., Chada, K., and Nagarajan, L. Preferential expression of HMGI-C isoforms lacking the acidic carboxy terminal in human leukemia. Biochem. Biophys. Res. Commun., 242: 452-456, 1998.
40. Screpanti, I., Scarpa, S., Meco, D., Bellavia, D., Stuppia, L., Frati, L., Modesti, A., and Gulino, A. Epidermal growth factor promotes a neural phenotype in thymic epithelial cells and enhances neuropoietic cytokine expression. J. Cell Biol., 130: 183-192, 1995.
41. Screpanti, I., Meco, D., Scarpa, S., Morrone, S., Frati, L., Gulino, A., and Modesti, A. Neuromodulatory loop mediated by nerve growth factor and interleukin 6 in thymic stromal cell cultures. Proc. Natl. Acad. Sci. USA, 89: 3209-3212, 1992.
42. Tkachenko, A., Ashar, H. R., Meloni, A. M., Sandberg, A. A., and Chada, K. K. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res., 57: 2276-2280, 1997.
43. Albemayor, E., and Sidell, N. Human neuroblastoma cell lines as model for the in vitro study of neoplastic and neuronal cell differentiation. Environ. Health Perspect., 80: 3-15, 1989.
44. Bolande, R. P. Spontaneous regression and cytodifferentiation of cancer in early life: the oncogenic grace period. Suev. Synth. Pathol. Res., 4: 296-311, 1985.
45. Thiele, C. J. Biology of pediatric peripheral neuroectodermal tumors. Cancer Metastasis Rev., 10: 311-319, 1991.
46. Finklestein, J. Z., Krailo, M. D., Lenarsky, C., Ladisch, S., Blair, G. K., Reynolds, C. P., Sitarz, A. L., and Hammond, G. D. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. Med. Pediatr. Oncol., 20: 307-311, 1992.
47. Peverali, F. A., Orioli, D., Tonon, L., Ciana, P., Bunone, G., Negri, M., and Della-Valle, G. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpression. Oncogene, 12: 457-462, 1996.
48. Giannini, G., Dawson, M. I., Zhang, X., and Thiele, C. J. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells. J. Biol. Chem., 272: 26693-26701, 1997.
49. Patel, U. A., Bandiera, A., Manfioletti, G., Giancotti, V., Chau, K. Y., and Crane-Robinson, C. Expression and cDNA cloning of human HMGI-C phosphoprotein. Biochem. Biophys. Res. Commun., 201: 63-70, 1994.
50. Johnson, K. R., Disney, J. E., Wyatt, C. R., and Reeves, R. Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferation. Exp. Cell Res., 187: 69-76, 1990.
51. Chau, K. Y., Patel, U. A., Lee, K. L., Lam, H. Y., and Crane-Robinson, C. The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element. Nucleic Acids Res., 23: 4262-4266, 1995.
52. Reynolds, C. P., Kane, D. J., Einhorn, P. A., Matthay, K. K., Crouse, V. L., Wilbur, J. R., Shurin, S. B., and Seeger, R. C. Response of neuroblastoma to retinoic acid in vitro and in vivo. Prog. Clin. Biol. Res., 366: 203-211, 1991.
53. Kaplan, D. R., Matsumoto, K., Lucarelli, E., and Thiele, C. J. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Neuron, 11: 321-331, 1993.
54. Gaetano, G., Matsumoto, K., and Thiele, C. J. Retinoic acid resistant neuroblastoma cells and expression of insulin-like growth factor-II. Prog. Clin. Biol. Res., 366: 165-172, 1991.
55. Matsumoto, K., Gaetano, C., Daughaday, W. H., and Thiele, C. J. Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. Endocrinology, 130: 3669-3676, 1992.
56. R) mediate resistance to retinoic acid-induced cell growth arrest in a human neuroblastoma cell line. Cell Death Differ., 1: 49-58, 1994.
57. Thiele, C. J., Reynolds, C. P., and Israel, M. A. Decreased expression of N-myc precedes retinoic acid induced morphological differentiation of human neuroblastoma. Nature (Lond.), 313: 404-406, 1985.
58. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
59. Caron, H., van Sluis, P., de Kraker, J., Bokkerink, J., Egeler, M., Laureys, G., Slater, R., Westerveld, A., Voute, P. A., and Versteeg, R. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med., 334: 225-230, 1996.
60. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Lelias, J. M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
61. Vallone, D., Battista, S., Pierantoni, G. M., Fedele, M., Casalino, L., Santoro, M., Viglietto, G., Fusco, A., and Verde, P. Neoplastic transformation of rat thyroid cells requires the junB and fra-I gene induction which is dependent on the HMGI-C gene product. EMBO J., 16: 5310-5321, 1997.
62. Schule, R., Umesono, K., Mangelsdorf, D. J., Bolado, J., Pike, I. W., and Evans, R. M. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell, 61: 497-504, 1990.
63. Schule, R., and Evans, R. M. Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet., 7: 377-381, 1991.
64. Tamimi, Y., van der Poel, H. G., Denyn, M. M., Umbas, R., Karthaus, H. F., Debruyne, F. M., and Schalken, J. A. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res., 53: 5512-5516, 1993.